Search research articles
Contact Us
Filters
Showing results (31-40 of 201) with videos related to
Page
of 21
Sort By:
The Journal of Biological Chemistry
|
February 8, 2007
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct
Mihaela Necula, Rakez Kayed, Saskia Milton, et al.
International Journal of Alzheimer'S Disease
|
August 29, 2012
Tau protein: function and pathology
Hanna Rosenmann, David Blum, Rakez Kayed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 10, 2023
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies
Sagar Gaikwad, Sudipta Senapati, Md Anzarul Haque, et al.
ACS Chemical Neuroscience
|
July 31, 2014
Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species
Julia E Gerson, Diana L Castillo-Carranza, Rakez Kayed
Brain Pathology (Zurich, Switzerland)
|
September 2, 2022
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
Mauro Montalbano, Lajja Majmundar, Urmi Sengupta, et al.
Brain Communications
|
September 6, 2024
Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers
Pietro Scaduto, Michela Marcatti, Nemil Bhatt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Shrinath Kadamangudi, Laura Sanchez, Agenor Limon, et al.
Frontiers in Bioscience (Scholar Edition)
|
January 2, 2013
Tau aggregates as immunotherapeutic targets
Diana L Castillo-Carranza, Cristian A Lasagna-Reeves, Rakez Kayed
Biomedicines
|
February 12, 2021
Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases
Filippa Lo Cascio, Paola Marzullo, Rakez Kayed, et al.
Immunotargets and Therapy
|
July 30, 2016
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Rakez Kayed
Page
of 21
Search research articles
Search
Showing results (31-40 of 201) with videos related to
Sort By:
Page
of 21
The Journal of Biological Chemistry
|
February 8, 2007
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct
Mihaela Necula, Rakez Kayed, Saskia Milton, et al.
International Journal of Alzheimer'S Disease
|
August 29, 2012
Tau protein: function and pathology
Hanna Rosenmann, David Blum, Rakez Kayed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 10, 2023
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies
Sagar Gaikwad, Sudipta Senapati, Md Anzarul Haque, et al.
ACS Chemical Neuroscience
|
July 31, 2014
Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species
Julia E Gerson, Diana L Castillo-Carranza, Rakez Kayed
Brain Pathology (Zurich, Switzerland)
|
September 2, 2022
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
Mauro Montalbano, Lajja Majmundar, Urmi Sengupta, et al.
Brain Communications
|
September 6, 2024
Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers
Pietro Scaduto, Michela Marcatti, Nemil Bhatt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Basic Science and Pathogenesis
Shrinath Kadamangudi, Laura Sanchez, Agenor Limon, et al.
Frontiers in Bioscience (Scholar Edition)
|
January 2, 2013
Tau aggregates as immunotherapeutic targets
Diana L Castillo-Carranza, Cristian A Lasagna-Reeves, Rakez Kayed
Biomedicines
|
February 12, 2021
Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases
Filippa Lo Cascio, Paola Marzullo, Rakez Kayed, et al.
Immunotargets and Therapy
|
July 30, 2016
Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Diana L Castillo-Carranza, Marcos J Guerrero-Muñoz, Rakez Kayed
Page
of 21